DK3765461T3 - Selektive protein argininmethyltransferase 5 (prmt5)-hæmmere - Google Patents

Selektive protein argininmethyltransferase 5 (prmt5)-hæmmere Download PDF

Info

Publication number
DK3765461T3
DK3765461T3 DK19714002.3T DK19714002T DK3765461T3 DK 3765461 T3 DK3765461 T3 DK 3765461T3 DK 19714002 T DK19714002 T DK 19714002T DK 3765461 T3 DK3765461 T3 DK 3765461T3
Authority
DK
Denmark
Prior art keywords
prmt5
inhibitors
methyl transferase
arginine methyl
protein arginine
Prior art date
Application number
DK19714002.3T
Other languages
English (en)
Inventor
Juan Luengo
Hong Lin
Michael Hawkins
Rupa Shetty
Philip Pitis
Villarroya Gisela Saborit
Original Assignee
Prelude Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Prelude Therapeutics Inc filed Critical Prelude Therapeutics Inc
Application granted granted Critical
Publication of DK3765461T3 publication Critical patent/DK3765461T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/24—Heterocyclic radicals containing oxygen or sulfur as ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/14—Pyrrolo-pyrimidine radicals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1003—Transferases (2.) transferring one-carbon groups (2.1)
    • C12N9/1007—Methyltransferases (general) (2.1.1.)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Peptides Or Proteins (AREA)
DK19714002.3T 2018-03-14 2019-03-14 Selektive protein argininmethyltransferase 5 (prmt5)-hæmmere DK3765461T3 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201862642727P 2018-03-14 2018-03-14
US201862666726P 2018-05-04 2018-05-04
US201862742048P 2018-10-05 2018-10-05
PCT/US2019/022288 WO2019178368A1 (en) 2018-03-14 2019-03-14 Selective inhibitors of protein arginine methyltransferase 5 (prmt5)

Publications (1)

Publication Number Publication Date
DK3765461T3 true DK3765461T3 (da) 2023-11-20

Family

ID=65952153

Family Applications (1)

Application Number Title Priority Date Filing Date
DK19714002.3T DK3765461T3 (da) 2018-03-14 2019-03-14 Selektive protein argininmethyltransferase 5 (prmt5)-hæmmere

Country Status (19)

Country Link
US (3) US11214574B2 (da)
EP (1) EP3765461B1 (da)
JP (1) JP7328241B2 (da)
KR (1) KR102803162B1 (da)
CN (1) CN111971288B (da)
AU (2) AU2019235912B2 (da)
BR (1) BR112020018636A2 (da)
CA (1) CA3092357A1 (da)
DK (1) DK3765461T3 (da)
ES (1) ES2963436T3 (da)
FI (1) FI3765461T3 (da)
IL (2) IL277263B2 (da)
MA (1) MA52005A (da)
MX (1) MX2020009555A (da)
PL (1) PL3765461T3 (da)
PT (1) PT3765461T (da)
UA (1) UA129992C2 (da)
WO (1) WO2019178368A1 (da)
ZA (1) ZA202005325B (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK3765461T3 (da) 2018-03-14 2023-11-20 Prelude Therapeutics Inc Selektive protein argininmethyltransferase 5 (prmt5)-hæmmere
JP2022526604A (ja) * 2019-04-05 2022-05-25 プレリュード・セラピューティクス・インコーポレイテッド タンパク質アルギニンメチルトランスフェラーゼ５の選択的阻害剤
CA3154566A1 (en) 2019-09-18 2021-03-25 Prelude Therapeutics Incorporated Selective inhibitors of protein arginine methyltransferase 5 (prmt5)
CA3259067A1 (en) * 2022-06-14 2023-12-21 Prelude Therapeutics Incorporated PROCESSES FOR MANUFACTURING PRMT5 INHIBITORS
WO2024170488A1 (en) 2023-02-13 2024-08-22 Astrazeneca Ab Prmt5 inhibitor for use in cancer therapy
WO2024249931A1 (en) * 2023-06-02 2024-12-05 University Of Florida Research Foundation, Incorporated Prmt5 inhibitors targeting mtap deleted cancers

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3657744A (en) 1970-05-08 1972-04-25 Univ Minnesota Method for fixing prosthetic implants in a living body
US4733665C2 (en) 1985-11-07 2002-01-29 Expandable Grafts Partnership Expandable intraluminal graft and method and apparatus for implanting an expandable intraluminal graft
US5023252A (en) 1985-12-04 1991-06-11 Conrex Pharmaceutical Corporation Transdermal and trans-membrane delivery of drugs
US5040548A (en) 1989-06-01 1991-08-20 Yock Paul G Angioplasty mehtod
US5350395A (en) 1986-04-15 1994-09-27 Yock Paul G Angioplasty apparatus facilitating rapid exchanges
US5061273A (en) 1989-06-01 1991-10-29 Yock Paul G Angioplasty apparatus facilitating rapid exchanges
US4748982A (en) 1987-01-06 1988-06-07 Advanced Cardiovascular Systems, Inc. Reinforced balloon dilatation catheter with slitted exchange sleeve and method
US5001139A (en) 1987-06-12 1991-03-19 American Cyanamid Company Enchancers for the transdermal flux of nivadipine
US4992445A (en) 1987-06-12 1991-02-12 American Cyanamid Co. Transdermal delivery of pharmaceuticals
CA1322628C (en) 1988-10-04 1993-10-05 Richard A. Schatz Expandable intraluminal graft
US5674278A (en) 1989-08-24 1997-10-07 Arterial Vascular Engineering, Inc. Endovascular support device
US5292331A (en) 1989-08-24 1994-03-08 Applied Vascular Engineering, Inc. Endovascular support device
US6344053B1 (en) 1993-12-22 2002-02-05 Medtronic Ave, Inc. Endovascular support device and method
PL2935222T3 (pl) * 2012-12-21 2019-02-28 Epizyme Inc Inhibitory PRMT5 i ich zastosowania
EP3160477A4 (en) 2014-06-25 2018-07-04 Epizyme, Inc. Prmt5 inhibitors and uses thereof
CN107406414B (zh) * 2015-01-09 2022-04-19 基因泰克公司 作为用于治疗癌症的组蛋白脱甲基酶kdm2b的抑制剂的(哌啶-3-基)(萘-2-基)甲酮衍生物
CU20170105A7 (es) * 2015-02-24 2017-10-05 Pfizer Derivados de nucleosidos sustituidos útiles como agentes antineoplásicos
AR104326A1 (es) * 2015-05-04 2017-07-12 Lilly Co Eli Compuestos nucleósidos 5-sustituidos
TWI870767B (zh) * 2015-08-26 2025-01-21 比利時商健生藥品公司 使用作為prmt5抑制劑之新穎經6-6雙環芳香環取代之核苷類似物
CA3016096C (en) 2016-03-10 2023-10-17 Janssen Pharmaceutica Nv Substituted nucleoside analogues for use as prmt5 inhibitors
WO2017218802A1 (en) 2016-06-15 2017-12-21 Prelude Therapeutics, Incorporated Selective inhibitors of protein arginine methyltransferase 5 (prmt5)
WO2018065365A1 (en) 2016-10-03 2018-04-12 Janssen Pharmaceutica Nv Novel monocyclic and bicyclic ring system substituted carbanucleoside analogues for use as prmt5 inhibitors
WO2018075601A1 (en) 2016-10-18 2018-04-26 Prelude Therapeutics, Incorporated Selective inhibitors of protein arginine methyltransferase 5 (prmt5)
WO2018085818A1 (en) 2016-11-07 2018-05-11 Prelude Therapeutics, Incorporated Selective inhibitors of protein arginine methyltransferase 5 (prmt5)
WO2018085833A2 (en) 2016-11-07 2018-05-11 Prelude Therapeutics, Incorporated Selective inhibitors of protein arginine methyl transferase 5 (prmt5)
WO2018152548A1 (en) 2017-02-20 2018-08-23 Prelude Therapeutics, Incorporated Selective inhibitors of protein arginine methyltransferase 5 (prmt5)
WO2018152501A1 (en) 2017-02-20 2018-08-23 Prelude Therapeutics, Incorporated Selective inhibitors of protein arginine methyltransferase 5 (prmt5)
WO2018160855A1 (en) 2017-03-01 2018-09-07 Prelude Therapeutics, Incorporated Selective inhibitors of protein arginine methyltransferase 5 (prmt5)
WO2018160824A1 (en) 2017-03-01 2018-09-07 Prelude Therapeutics, Incorporated Selective inhibitors of protein arginine methyltransferase 5 (prmt5)
CA3072439A1 (en) 2017-08-09 2019-02-14 Prelude Therapeutics, Incorporated Selective inhibitors of protein arginine methyltransferase 5 (prmt5)
US11524962B2 (en) 2017-10-26 2022-12-13 Prelude Therapeutics, Incorporated Substituted pyrrolo[2,3-d]pyrimidines as inhibitors of protein arginine methyl transferase 5 (PRMT5)
US10711007B2 (en) * 2018-03-14 2020-07-14 Prelude Therapeutics Incorporated Selective inhibitors of protein arginine methyltransferase 5 (PRMT5)
DK3765461T3 (da) 2018-03-14 2023-11-20 Prelude Therapeutics Inc Selektive protein argininmethyltransferase 5 (prmt5)-hæmmere

Also Published As

Publication number Publication date
IL277263A (en) 2020-10-29
CN111971288B (zh) 2023-12-01
EP3765461A1 (en) 2021-01-20
AU2019235912B2 (en) 2024-03-21
FI3765461T3 (fi) 2023-11-13
AU2024204264A1 (en) 2024-07-11
US11214574B2 (en) 2022-01-04
US20200291037A1 (en) 2020-09-17
US12459950B2 (en) 2025-11-04
MX2020009555A (es) 2021-01-20
CN111971288A (zh) 2020-11-20
UA129992C2 (uk) 2025-10-08
WO2019178368A1 (en) 2019-09-19
IL277263B1 (en) 2024-03-01
KR102803162B1 (ko) 2025-04-30
IL277263B2 (en) 2024-07-01
KR20200132916A (ko) 2020-11-25
JP7328241B2 (ja) 2023-08-16
PT3765461T (pt) 2023-11-14
EP3765461B1 (en) 2023-08-30
PL3765461T3 (pl) 2024-03-04
US20200361945A1 (en) 2020-11-19
ZA202005325B (en) 2025-09-25
JP2021515788A (ja) 2021-06-24
AU2019235912A1 (en) 2020-10-01
BR112020018636A2 (pt) 2020-12-29
MA52005A (fr) 2021-01-20
US11254683B2 (en) 2022-02-22
ES2963436T3 (es) 2024-03-27
IL310675A (en) 2024-04-01
CA3092357A1 (en) 2019-09-19
US20220177481A1 (en) 2022-06-09

Similar Documents

Publication Publication Date Title
DK3665179T3 (da) Selektive inhibitorer af proteinargininmethyltransferase 5 (prmt5)
DK3765461T3 (da) Selektive protein argininmethyltransferase 5 (prmt5)-hæmmere
IL283639A (en) Kif18a inhibitors
IL286462A (en) Protein tyrosine phosphatase inhibitors
EP3867238C0 (en) PROTEIN TYROSINE PHOSPHATASE INHIBITORS
MA53287A (fr) Inhibiteurs de prmt5
MA51616A (fr) Inhibiteurs d'adn-pk
LT3980417T (lt) Prmt5 inhibitoriai
EP3952874A4 (en) SELECTIVE INHIBITORS OF PROTEIN ARGININE METHYLTRANSFERASE 5
EP3768671C0 (en) SUBSTITUTED IMIDAZOLIDIN-2-ONE DERIVATIVES AS PRMT5 INHIBITORS
DK3833348T3 (da) Transglutaminase 2 (TG2)-inhibitorer
EP3850007A4 (en) Engineered bispecific proteins
MA52004A (fr) Inhibiteurs d'o-glycoprotéine-2-acétamido-2-désoxy-3-d-glycopyranosidase
EP3946352A4 (en) SELECTIVE INHIBITORS OF PROTEIN ARGININE METHYLTRANSFERASE 5
EP3679031A4 (en) INHIBITORS OF WDR5 PROTEIN PROTEIN BINDING
EP3746430A4 (en) INHIBITORS OF PROTEIN ARGININE DEIMINASES
EP4077282A4 (en) Prmt5 inhibitors
PL4010330T3 (pl) Pochodne chinoliny jako inhibitory kinazy białkowej
HUE056885T2 (hu) CREB-kötõ fehérjék inhibitorai
EP3833668A4 (en) PRMT5 INHIBITORS
EP3833669A4 (en) PRMT5 INHIBITORS
EP3946288A4 (en) SUBSTITUTED 5-CYCLOPROPYL-1H-PYRAZOL-3-YL-AMINE DERIVATIVES USED AS SELECTIVE CDK12/13 INHIBITORS
EP3774768A4 (en) Substituted pyrazole derivatives as selective cdk12/13 inhibitors
IL281514A (en) O-glycoprotein-2-acetamido-2-deoxy-3-d-glucopyranosidase inhibitors
IL285536A (en) A selective inhibitor of protein arginine methyltransferase 5